Astma Allergi Shoppen ApS

The financial health of Astma Allergi Shoppen ApS shows a significant upward trajectory, with revenue increasing from 4.75 million DKK in 2023 to 11.44 million DKK in 2024, reflecting strong growth. Profitability has also improved, rising from 7,161 DKK to 204,193 DKK during the same period, although profit margins remain modest. The company's equity has increased to 392,784 DKK, indicating a strengthening financial position, yet the overall equity remains low relative to its revenue. As a player in the retail sector for new goods, the company is gaining traction, but its relatively small size and limited historical data suggest potential vulnerabilities that should be monitored.

AI-generated summary